Pathological complete response to neoadjuvant lorlatinib in a patient with stage IIIA ALK -positive non-small cell lung cancer: a case report.
Li LuZhengqi CaoAnni WangLixuan ChenJing SunZiming LiPublished in: Translational lung cancer research (2024)